Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
search
Subscribe
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
Subscribe
FREE
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Oral Microbiota May Predict Pancreatic Cancer Risk
September 2025
Oral bacteria and fungi have been identified as risk factors for the development of pancreatic cancer, making them potential non-invasive biomarkers for identifying individuals at high risk.
Read more
15 Jun 2024
Combination Therapy in Prostate Cancer Associated with Increased Cardiovascular Risk
Recent research indicates heightened cardiovascular risks when combining androgen receptor signalling inhibitors with androgen deprivation therapy in prostate cancer treatment.
9 Jun 2024
New Surgical Platform Rapidly Identifies Isocitrate Dehydrogenase Mutations in Gliomas
A study reports of a new surgical platform capable of identifying isocitrate dehydrogenase mutations in gliomas in under two minutes.
9 Jun 2024
Perioperative FLOT Outperforms Neoadjuvant Chemoradiation in Esophageal Cancer Survival
A recent study found that perioperative FLOT chemotherapy significantly improves survival rates in patients with esophageal adenocarcinoma.
7 Jun 2024
IMROZ Multiple Myeloma Study Results: Abstracts from ASCO 2024
Read results from a trial presented as ASCO 2024, which details the impact that Isa-VRd therapy has in multiple myeloma patients
7 Jun 2024
Durvalumab as Consolidation Treatment in ADRIATIC Trial: Abstracts from ASCO 2024 Plenary Session
Read the latest news from ASCO 2024, including on results from the ADRIATIC trial on small-cell lung cancer post-chemoradiotherapy.
7 Jun 2024
Lung Cancer Screening More Beneficial in Lower Socioeconomic Groups
New research reveals low-dose CT benefits lower socioeconomic groups, reducing COPD and emphysema mortality
6 Jun 2024
The NADINA Trial Revolutionizes Treatment for Stage III Melanoma: Abstracts from ASCO 2024 Plenary Session
Read the latest research from ASCO 2024, including a trial on treatment that improves event-free survival in Stage III melanoma.
31 May 2024
Melanoma – An Inherited Cancer?
According to a recent study from the Cleveland Clinic, genes may play a significantly larger role in melanoma risk than previously believed
Loading posts...
« Previous
1
…
23
24
25
26
27
…
54
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View